Faculty
Raiees Ahmad Andrabi, PhD

Associate Professor of Medicine (Infectious Diseases)
Department: Medicine
Graduate Group Affiliations
Contact information
Division of Infectious Diseases
Perelman School of Medicine
University of Pennsylvania
522E Johnson Pavilion
3610 Hamilton Walk
Philadelphia, PA 19104
Perelman School of Medicine
University of Pennsylvania
522E Johnson Pavilion
3610 Hamilton Walk
Philadelphia, PA 19104
Lab: 215-573-5041
Publications
Education:
B.Sc. (Biology)
University of Kashmir, Srinagar, India, 2005.
M.Sc (Biochemistry)
Hamdard University, New Delhi, India, 2007.
PhD (Biochemistry/Philosophy)
All India Institute of Medical Sciences (AIIMS) New Delhi, India, 2012.
Permanent linkB.Sc. (Biology)
University of Kashmir, Srinagar, India, 2005.
M.Sc (Biochemistry)
Hamdard University, New Delhi, India, 2007.
PhD (Biochemistry/Philosophy)
All India Institute of Medical Sciences (AIIMS) New Delhi, India, 2012.
Description of Research Expertise
A major focus in the Andrabi laboratory is to utilize in vitro directed evolution platform combined with structure-guided design approaches to develop vaccine immunogens against complex pathogens such as HIV, Influenza virus, Arenaviruses and Coronaviruses. The other major area of research in his laboratory is to understand the immunological basis of B cell affinity maturation pathways to complex antigen surfaces, both in vaccination and in infection and to utilize this information for designing more effective vaccines. The overall goal is to design vaccine immunogens and immunization strategies that can induce protective broadly neutralizing antibody responses against complex pathogens through vaccination in humans.Selected Publications
Zhou P, Song G, He WT, Beutler N, Tse LV, Martinez DR, Schr A, Anzanello F, Yong P, Peng L, Dueker K, Musharrafieh R, Callaghan S, Capozzola T, Yuan M, Liu H, Limbo O, Parren M, Garcia E, Rawlings SA, Smith DM, Nemazee D, Jardine JG, Wilson IA, Safonova Y, Rogers TF, Baric RS, Gralinski LE, Burton DR, Andrabi R.: Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease. Immunity 56(3): 669–686, Mar 2023.He WT, Musharrafieh R, Song G, Dueker K, Tse LV, Martinez DR, Sch�r A, Callaghan S, Yong P, Beutler N, Torres JL, Volk RM, Zhou P, Yuan M, Liu H, Anzanello F, Capozzola T, Parren M, Garcia E, Rawlings SA, Smith DM, Wilson IA, Safonova Y, Ward AB, Rogers TF, Baric RS, Gralinski LE, Burton DR, Andrabi R.: Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses. Nat Immunol 23(1): 960-970, June 2022.
Zhou P, Yuan M, Song G, Beutler N, Shaabani N, Huang D, He WT, Zhu X, Callaghan S, Yong P, Anzanello F, Peng L, Ricketts J, Parren M, Garcia E, Rawlings SA, Smith DM, Nemazee D, Teijaro JR, Rogers TF, Wilson IA, Burton DR, Andrabi R: A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection. Science Translational Medicine 14(637): 8, Feb 2022.
He WT, Yuan M, Callaghan S, Musharrafieh R, Song G, Silva M, Beutler N, Lee WH, Yong P, Torres JL, Melo M, Zhou P, Zhao F, Zhu X, Peng L, Huang D, Anzanello F, Ricketts J, Parren M, Garcia E, Ferguson M, Rinaldi W, Rawlings SA, Nemazee D, Smith DM, Briney B, Safonova Y, Rogers TF, Dan JM, Zhang Z, Weiskopf D, Sette A, Crotty S, Irvine DJ, Ward AB, Wilson IA, Burton DR, Andrabi R.: Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques. Sci Transl Med 14(657): eabl9605, Aug 2022.
Song G, He WT, Callaghan S, Anzanello F, Huang D, Ricketts J, Torres JL, Beutler N, Peng L, Vargas S, Cassell J, Parren M, Yang L, Ignacio C, Smith DM, Voss JE, Nemazee D, Ward AB, Rogers T, Burton DR, Andrabi R.: Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection. Nat Commun 12(2938): 2938, May 2021.
Andrabi R, Pallesen J, Allen JD, Song G, Zhang J, de Val N, Gegg G, Porter K, Su CY, Pauthner M, Newman A, Bouton-Verville H, Garces F, Wilson IA, Crispin M, Hahn BH, Haynes BF, Verkoczy L, Ward AB, Burton DR.: The Chimpanzee SIV Envelope Trimer: Structure and Deployment as an HIV Vaccine Template. Cell Rep 27(8): 2426-2441, May 2019.
Andrabi R, Bhiman JN, Burton DR.: Strategies for a multi-stage neutralizing antibody-based HIV vaccine. Curr Opin Immunol 53(1), Aug 2018.
Andrabi R, Su CY, Liang CH, Shivatare SS, Briney B, Voss JE, Nawazi SK, Wu CY, Wong CH, Burton DR.: Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development. Immunity 47(3): 1004, Nov 2017.
Lee JH, Andrabi R, Su CY, Yasmeen A, Julien JP, Kong L, Wu NC, McBride R, Sok D, Pauthner M, Cottrell CA, Nieusma T, Blattner C, Paulson JC, Klasse PJ, Wilson IA, Burton DR, Ward AB.: A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic ?-Hairpin Structure. Immunity 46(4): 690-702, Apr 2017.
Andrabi R, Voss JE, Liang CH, Briney B, McCoy LE, Wu CY, Wong CH, Poignard P, Burton DR.: Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design. Immunity 43(5): 959-73, Nov 2015.
© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Site Design: PMACS Web Team.